You Position: Home > Paper
Antibody-drug conjugates as targeted cancer therapeutics
( views:37, downloads:0 )
- Author:
- No author available
- Journal Title:
- ACTA PHARMACEUTICA SINICA
- Issue:
- 9
- DOI:
- 10.3321/j.issn:0513-4870.2009.09.002
- Key Word:
- 抗体-药物偶联物;靶向癌症治疗;内在化;构成;antibody-drug conjugate;targeted cancer therapeutics;internalization;component
Abstract： operty, liability and activity.
- [1]Buick RJ,Walker B,Olwill SA,etc.Antibody conjugates and therapeutic strategies.[J].2005,5(6).
- [2]Chari RVJ.Targeted cancer therapy: Conferring specificity to cytotoxic drugs[J].2008,41(1).
- [3]Jurgen C. Becker,Ralph A. Reisfel d,David Schrama.Antibody targeted drugs as cancer therapeutics[J].2006,5(2).
- [4]赵杰,曹胜利,郑晓霖,等.叶酸受体介导的抗肿瘤药物研究进展[J].2009,(2).
- [5]F L, Moolten,S R, Cooperband.Selective destruction of target cells by diphtheria toxin conjugated to antibody directed against antigens on the cells.[J].1970,169.
- [6]Kim K,Hamblett KJ,Francisco JA,etc.Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment[J].2006,19(7).
- [7]Lee M.Greenberger,Clara Lin,Ana T.Menendez,etc.An Anti-MUCl Antibody-Calicheamicin Conjugate for Treatment of Solid Tumors.Choice of Linker and Overcoming Drug Resistance[J].2005,16(2).
- [8]Meyer DW,Toki BE,Burke PJ.Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system.[J].2009,19(10).
- [9]Ulbrich K,Etrych T,Chytil P,etc.Antibody-targeted Polymer-doxorubicin Conjugates with pH-controlled Activation.[J].2004,12(8).
- [10]Willemze R,van Dongen JJ,Jedema I,etc.Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity.[J].2004,18(2).
- [11]Svetlana O, Doronina,Brian E, Toki,Michael Y, Torgov,etc.Development of potent monoclonal antibody auristatin conjugates for cancer therapy.[J].2003,21(7).
- [12]Simpson M,Dennis MS,Junutula JR,etc.Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.[J].2008,26(8).
- [13]Jaracz S,Kuznetsova LV,Ojima I,etc.Recent advances in tumor-targeting anticancer drug conjugates.[J].2005,13(17).
- [14]Irwin Hollander,Arthur Kunz,Philip R. Hamann.Selection of Reaction Additives Used in the Preparation of Monomeric Antibody-Calicheamicin Conjugates[J].2008,19(1).
- [15]Lewis TS,Cerveny CG,Meyer DL,etc.Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates.[J].2006,281(15).
- [16]Senter PD,Jeffrey SC,Andreyka JB,etc.Dipeptide-based highly potent doxorubicin antibody conjugates.[J].2006,16(2).
- [17]Xie H,Qu C,Borella CP,etc.Tumor-specific novel taxoid-monoclonal antibody conjugates.[J].2002,45(26).